MobileODT

MobileODT, **founded in 2012**, is a biotechnology and healthcare startup with the slogan "Empowering healthcare providers everywhere with smart, connected visual diagnostic tools, improving access, reducing costs, and enhancing outcomes." The company has developed the Enhanced Visual Assessment (EVA) System, **garnering a $4.00M Series C investment on 12 August 2020** from notable investors including **Laerdal Million Lives Fund, OrbiMed, Tara Health Foundation, and Tristel**. EVA, an FDA-cleared mobile colposcope, has gained significant market share in the US, Africa, and India, with over 40,000 procedures conducted across 29 countries. Notably, **leading hospitals such as MD Anderson, Mount Sinai, and Apollo** utilize EVA, and the system is increasingly becoming a standard tool for visualization in the United States, with **over 20% of hospitals in New York State** offering Sexual Assault Forensic Examinations employing it. The company is rapidly expanding into new regions and developing visual-based applications for ENT, oral disease, and skin, signaling promising growth in the biotech and healthcare sectors.